Interview with Michael Pehl, Managing Director, Celgene Germany
Celgene is very new in the German market. What would you say have been the main achievements of Celgene Germany since its establishment in 2006? Celgene Germany started as a…
Address: Lengeder Straße 42a, 13407 Berlin-Reinickendorf ,Germany
Tel: +49 30 40 90 08-0
Web: http://www.ct-arzneimittel.de/index.php?id=20
CT is a specialist pharmaceutical company which focuses on the production of generics. Founded in 1917, and now presided over by Carston Cron, CT is one of the Top ten generics companies in Germany market, employing around 200 peopleFor the most part, the company’s product portfolio concentrates on prescription medicines, with a range of over 1,200 drugs, in varying combinations of over 200 substances. A large majority of its products are Over-the-Counter (or OTC) medicines and health products, with the aim of treating common, everyday illnesses. The oldest and most well-renowned brand-name product in CT’s OTC range is Tussamag ®, a cough and cold medicine. However other specialist indications include products in the specialist areas of: Neurology, pain, urology, and oncology.
Celgene is very new in the German market. What would you say have been the main achievements of Celgene Germany since its establishment in 2006? Celgene Germany started as a…
Could you briefly present the Association of German Biotechnology Companies (VBU) and DECHEMA e.V. to our readers and describe their importance to the German biotechnology industry? VBU is a non…
Hospira, which was spun-off from Abbott Laboratories in 2004, is a global specialty pharmaceutical and medication delivery company driven by its vision of Advancing Wellness™. Bringing proven leadership and experience,…
How challenging is for you as General Manager of Nycomed Germany to lead the number one subsidiary of the Nycomed Group and what would you highlight as the key milestones…
The acquisition of IVAX in 2006 was decisive to establish Teva as the number one generic producer worldwide and further consolidate the company in the German market; and this process…
See our Cookie Privacy Policy Here
